Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced plans to
participate in the upcoming virtual H.C. Wainwright Global Life
Management is scheduled to participate and hold one-on-one
meetings Tuesday, March 9, 2021. A presentation webcast will be
available in advance of the event on the same morning at 7:00am ET.
Interested parties may access a recorded webcast of the
presentation on the “Investor Relations” section of the company’s
website at www.senseonics.com.
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
version on businesswire.com: https://www.businesswire.com/news/home/20210302006168/en/
Senseonics Investor Relations Contact: Lynn Lewis or
Philip Taylor Investor Relations 415-937-5406